Mark Hillman's CVS Position Overview
Mark Hillman (via Hillman Capital Management, Inc.) currently holds 82.4K shares of CVS Health Corporation (CVS) worth $6.21 M, representing 3.61% of the portfolio. First purchased in 2019-Q4, this long-term strategic position has been held for 24 quarters.
Based on 13F filings, Mark Hillman has maintained a strategic position in CVS, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 16.6K shares. Largest reduction occurred in Q1 2025, reducing 19.2K shares.
Analysis based on 13F filings available since 2013 Q2
Mark Hillman's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Mark Hillman
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2019 | +71,207 | Add 0.00% | 71,206 | $74.29 |
| Q1 2020 | -286 | Reduce 0.40% | 70,920 | $59.33 |
| Q2 2020 | +18 | Add 0.03% | 70,938 | $64.97 |
| Q3 2020 | +10,158 | Add 14.32% | 81,096 | $58.40 |
| Q4 2020 | +13,169 | Add 16.24% | 94,265 | $68.30 |
| Q1 2021 | +13,954 | Add 14.80% | 108,219 | $75.23 |
| Q2 2021 | +710 | Add 0.66% | 108,929 | $83.44 |
| Q3 2021 | +3,912 | Add 3.59% | 112,841 | $84.86 |
| Q4 2021 | -3,743 | Reduce 3.32% | 109,098 | $103.16 |
| Q1 2022 | -11,615 | Reduce 10.65% | 97,483 | $101.22 |
| Q2 2022 | -173 | Reduce 0.18% | 97,310 | $92.66 |
| Q3 2022 | -968 | Reduce 0.99% | 96,342 | $95.37 |
| Q4 2022 | -707 | Reduce 0.73% | 95,635 | $93.19 |
| Q1 2023 | +712 | Add 0.74% | 96,347 | $74.31 |
| Q2 2023 | -652 | Reduce 0.68% | 95,695 | $69.13 |
| Q3 2023 | +16,613 | Add 17.36% | 112,308 | $69.82 |
| Q4 2023 | +1,354 | Add 1.21% | 113,662 | $78.96 |
| Q1 2024 | +376 | Add 0.33% | 114,038 | $79.76 |
| Q2 2024 | +10,291 | Add 9.02% | 124,329 | $59.06 |
| Q3 2024 | -2,802 | Reduce 2.25% | 121,527 | $62.88 |
| Q4 2024 | -1,891 | Reduce 1.56% | 119,636 | $44.89 |
| Q1 2025 | -19,186 | Reduce 16.04% | 100,450 | $67.75 |
| Q2 2025 | -7,453 | Reduce 7.42% | 92,997 | $68.98 |
| Q3 2025 | -10,638 | Reduce 11.44% | 82,359 | $75.39 |
Mark Hillman's CVS Health Corporation Investment FAQs
Mark Hillman first purchased CVS Health Corporation (CVS) in Q4 2019, acquiring 71,206 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mark Hillman has held CVS Health Corporation (CVS) for 24 quarters since Q4 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mark Hillman's largest addition to CVS Health Corporation (CVS) was in Q4 2019, adding 71,206 shares worth $5.29 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Mark Hillman's firm, Hillman Capital Management, Inc., owns 82,359 shares of CVS Health Corporation (CVS), valued at approximately $6.21 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, CVS Health Corporation (CVS) represents approximately 3.61% of Mark Hillman's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mark Hillman's peak holding in CVS Health Corporation (CVS) was 124,329 shares, as reported at the end of Q2 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.